Global demand for dural graft is expected to grow significantly, owing to rising burden of neurosurgical diseases leading to increasing cranial and spinal duraplasty, and rapid technological advancements in dural graft products. Moreover, increasing global neurosurgical workforce, extensive clinical research, and increasing demand for CNS dural repair are responsible for increasing the adoption of dural graft products. For instance, in 2004, the World Health Organization (WHO) estimated that, there were 33,193 neurosurgeons worldwide, including trainees. Whereas, in 2015, this number rose to approximately 49,940 neurosurgeons, with a 4% total growth, worldwide.
Persistence Market Research predicts that, the global dural graft market will exhibit a 6% CAGR during the forecast period (2019-2029).
Key Takeaways of Dural Graft Market Study
- By product type, synthetic dural graft along with xenogeneic dural graft are expected to gain traction during the forecast period.
- Technological advancements in material science of dural graft products in North America and Europe are expected to contribute to the significant dominance of these regions during the forecast period.
- Brain and spine tumor applications are expected to hold more than 50% share in the global dural graft market.
- Synthetic polymer material is expected to gain significant traction and experience 2X demand by 2029.
- Leading dural graft manufacturing companies are partnering with innovative product developers and specialized distributors to strengthen their market position.
- Rising healthcare expenditure and increasing neurosurgeon workforce density in East Asia are expected to offer significant opportunities for market growth.
“Increasing scientific evidence from industry-led clinical trials and technological advancements in dural graft products are expected to support the significant adoption of synthetic nanofibrous dural grafts.” says a PMR analyst.
Brain and Spinal Tumor Application Dominating Dural Graft Market
Prevalence of CNS tumors due to neurological conditions is growing rapidly. Chiari malformation and spinal cord tumor-related neurosurgical procedures requiring dural grafts for surgeries are becoming more frequent. Growing risk of such neurological conditions demands neurosurgical procedures along with duraplasty for effective and safe treatment outcomes. For instance, in 2018, more than 50% of dural grafts were used in cranial and spine tumor operations. This high proportion is estimated to continue in the future.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the dural graft market in its latest study, presenting historical demand assessment from 2014-2018 and projections for 2019-2029, on the basis of product type (xenogeneic dural graft, synthetic dural graft, autologous dural graft, and allogeneic dural graft), application (brain and spine tumor, traumatic brain and spine injury, cerebrospinal fluid (CSF) accumulation, cerebrovascular accident, epilepsy, and others), material (bovine pericardium, autologous pericardium, synthetic polymers, ligamentum nuchae, and others), and end user (hospitals, ambulatory surgical centers, trauma centers, and clinics), across seven key regions.
For additional insights on how the growth of the dural graft market will unfold over the next decade, write to the analyst at email@example.com
PMR’s Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.